TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2016

Correlative Analysis of Genetic Alterations and Everolimus Benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From BOLERO-2.

Gabriel N Hortobagyi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.